Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia
出版年份 2012 全文链接
标题
Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia
作者
关键词
-
出版物
CELL CYCLE
Volume 11, Issue 13, Pages 2467-2475
出版商
Informa UK Limited
发表日期
2012-07-04
DOI
10.4161/cc.20859
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A critical role for the NFkB pathway in multiple myeloma
- (2015) Oncotarget
- Exploiting p53 Status to Enhance Effectiveness of Chemotherapy by Lowering Associated Toxicity
- (2015) Linda S. Steelman et al. Oncotarget
- The NFκB pathway: a therapeutic target in glioblastoma
- (2015) Lorena Nogueira et al. Oncotarget
- Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop
- (2012) Fabio Valenti et al. CELL CYCLE
- Fine-tuning of the intracellular canonical Notch signaling pathway
- (2012) Tilman Borggrefe et al. CELL CYCLE
- Ligand-driven activation of the Notch pathway in T-all and solid tumors: Why Not(ch)?
- (2011) Stefano Indraccolo et al. CELL CYCLE
- Tensin2 is a novel mediator in thrombopoietin (TPO)-induced cellular proliferation by promoting Akt signaling
- (2011) Andre Scott Jung et al. CELL CYCLE
- MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks
- (2011) Michael Fraser et al. CELL CYCLE
- Mechanism of action of the multikinase inhibitor Foretinib
- (2011) Maeva Dufies et al. CELL CYCLE
- The NFκB paradox: RelB induces and inhibits gene expression
- (2011) Lisa A. Madge et al. CELL CYCLE
- Sensitivity of acute myeloid leukemia Kasumi-1 cells to binase toxic action depends on the expression ofKITandАML1-ETOoncogenes
- (2011) Vladimir A. Mitkevich et al. CELL CYCLE
- Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think: Table I.
- (2011) Camille Lobry et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Apoptotic Role of IKK in T-ALL Therapeutic Response
- (2011) I. Riz et al. MOLECULAR CANCER RESEARCH
- Notch in T-ALL: new players in a complex disease
- (2011) Ute Koch et al. TRENDS IN IMMUNOLOGY
- I B kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia
- (2010) N. Chapuis et al. BLOOD
- Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia
- (2010) Maddalena Paganin et al. BLOOD REVIEWS
- The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia
- (2010) Lluis Espinosa et al. CANCER CELL
- Highly Phosphorylated FOXO3A Is an Adverse Prognostic Factor in Acute Myeloid Leukemia
- (2010) S. M. Kornblau et al. CLINICAL CANCER RESEARCH
- Akt inhibitors in clinical development for the treatment of cancer
- (2010) Sumanta Kumar Pal et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL–BFM 2000 protocol can be separated from FBXW7 loss of function
- (2010) C Kox et al. LEUKEMIA
- Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study
- (2010) Amanda L Cleaver et al. Molecular Cancer
- Regulation and Function of NF-κB Transcription Factors in the Immune System
- (2009) Sivakumar Vallabhapurapu et al. Annual Review of Immunology
- A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in Cancer
- (2009) J.-Y. Yang et al. CLINICAL CANCER RESEARCH
- Acute lymphoblastic leukaemia
- (2008) Ching-Hon Pui et al. LANCET
- ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
- (2008) Jer-Yen Yang et al. NATURE CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started